Bionomics Balance Sheet Health
Financial Health criteria checks 6/6
Bionomics has a total shareholder equity of $17.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $22.9M and $5.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$8.08m |
Equity | US$17.07m |
Total liabilities | US$5.85m |
Total assets | US$22.92m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: B1N0's short term assets ($8.4M) exceed its short term liabilities ($2.6M).
Long Term Liabilities: B1N0's short term assets ($8.4M) exceed its long term liabilities ($3.3M).
Debt to Equity History and Analysis
Debt Level: B1N0 is debt free.
Reducing Debt: B1N0 has no debt compared to 5 years ago when its debt to equity ratio was 111.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: B1N0 has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: B1N0 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.